Monthly Belimumab Infusions Preserve Kidney Function in Some Lupus Patients

(Reuters Health)—Intravenous belimumab combined with standard lupus therapy can help preserve kidney function in patients with active lupus nephritis and cut the odds of death or a renal-related event by half, a phase 3 multinational study has concluded.1 After two years of therapy, 43% of 224 volunteers getting the drug monthly showed a renal response... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Drug Updates belimumab kidney Lupus nephritis SLE systemic lupus erythematosus (SLE) Source Type: research